Insulet Corporation (PODD) PT Lowered to $277 at Goldman Sachs

April 9, 2026 5:56 AM

Goldman Sachs analyst David Roman lowered the price target on Insulet Corporation (NASDAQ: PODD) to $277.00 (from $326.00) while maintaining a Buy rating.

No results found